Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 11.94 is 25% below its 5-year average of 16.00, near the low end of its 5-year range (7.37–30.79).
As of the fiscal period ended Tuesday, June 30, 2026. 9.59% above its 12-month average of 10.90.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 11.94.
QUICK RATIO (ACID-TEST)
11.94
QUICK RATIO (ACID-TEST) AVG TTM
10.90
QUICK RATIO (ACID-TEST) AVG 3Y
14.25
QUICK RATIO (ACID-TEST) AVG 5Y
16.00
QUICK RATIO (ACID-TEST) AVG 10Y
16.81
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.59%
CURRENT VS 3Y AVG
-16.22%
CURRENT VS 5Y AVG
-25.38%
CURRENT VS 10Y AVG
-28.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
+256.43%
vs the sector median at left
Pharvaris N.V.
Market Cap
$2.17B
Quick Ratio (Acid-Test)
11.94
TTM Avg
10.90
3Y Avg
14.25
5Y Avg
16.00
Market Cap
$2.11B
Quick Ratio (Acid-Test)
18.83
TTM Avg
6.22
3Y Avg
3.45
5Y Avg
3.57
Market Cap
$2.11B
Quick Ratio (Acid-Test)
1.69
TTM Avg
1.73
3Y Avg
1.64
5Y Avg
1.89
Market Cap
$2.08B
Quick Ratio (Acid-Test)
10.92
TTM Avg
19.66
3Y Avg
12.98
5Y Avg
14.20
Market Cap
$2.07B
Quick Ratio (Acid-Test)
4.69
TTM Avg
4.29
3Y Avg
4.33
5Y Avg
4.67
Market Cap
$2.06B
Quick Ratio (Acid-Test)
11.82
TTM Avg
14.70
3Y Avg
15.08
5Y Avg
16.52
Market Cap
$2.28B
Quick Ratio (Acid-Test)
3.45
TTM Avg
3.42
3Y Avg
3.65
5Y Avg
3.62
Market Cap
$2.29B
Quick Ratio (Acid-Test)
2.98
TTM Avg
6.17
3Y Avg
6.76
5Y Avg
6.11
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pharvaris N.V. (PHVS) | $2.17B | 11.94 | 10.90 | 14.25 | 16.00 |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 18.83 | 6.22 | 3.45 | 3.57 |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 1.69 | 1.73 | 1.64 | 1.89 |
| Vera Therapeutics, Inc. (VERA)vs › | $2.08B | 10.92 | 19.66 | 12.98 | 14.20 |
| Vericel Corporation (VCEL)vs › | $2.07B | 4.69 | 4.29 | 4.33 | 4.67 |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | 11.82 | 14.70 | 15.08 | 16.52 |
| Alvotech (ALVO)vs › | $2.06B | 0.96 | 1.42 | 1.06 | 1.08 |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 3.45 | 3.42 | 3.65 | 3.62 |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | 2.98 | 6.17 | 6.76 | 6.11 |
| Fortrea Holdings Inc. (FTRE)vs › | $2.04B | 0.96 | 0.99 | 1.34 | 1.34 |
Quick Ratio
11.94
Excludes inventory
Current Ratio
11.94
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 11.94 |
| 2026-03-31 | 11.24 |
| 2025-12-31 | 10.11 |
| 2025-09-30 | 12.86 |
| 2025-06-30 | 8.33 |
| 2025-03-31 | 11.10 |
| 2024-12-31 | 12.60 |
| 2024-09-30 | 19.08 |
| 2024-06-30 | 18.45 |
| 2024-03-31 | 20.53 |
| 2023-12-31 | 27.25 |
| 2023-09-30 | 10.46 |
| 2023-06-30 | 11.35 |
| 2023-03-31 | 7.37 |
| 2022-12-31 | 8.93 |
| 2022-09-30 | 11.43 |
| 2022-06-30 | 12.85 |
| 2022-03-31 | 19.84 |
| 2021-12-31 | 30.28 |
| 2021-09-30 | 29.26 |
| 2021-06-30 | 30.79 |
| 2021-04-30 | 28.87 |
| 2020-12-31 | 19.00 |
| 2020-09-30 | 9.86 |
| 2020-06-30 | 19.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 10.70 |
| 2019-09-30 | 10.70 |
| 2019-06-30 | 10.70 |
| 2019-03-31 | 10.70 |
| 2018-12-31 | 11.29 |
| 2018-09-30 | 11.29 |
| 2018-06-30 | 11.29 |
| 2018-03-31 | 11.29 |
| 2017-12-31 | 34.55 |
| 2017-09-30 | 34.55 |
| 2017-06-30 | 34.55 |
| 2017-03-31 | 34.55 |
